Loading live market data…

Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

$3.31 USD

-$0.03 (-0.9%)

Volume
19.26M
Average Volume
19.03M
Market Capitalization
$1.48B
P/E Ratio
-2.76
Dividend Yield
0.00%
Price Target
$5.50
Year High
$7.18
Year Low
$2.77
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.47

RXRX Estimated and Actual Revenue by Quarter

RXRX Estimated and Actual EPS by Quarter

RXRX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 2 -7.77M -2.69M -5.2M -7.77M -2.69M -5.2M
2028-09-30 1 -7.77M -2.69M -5.2M -7.77M -2.69M -5.2M
2028-06-30 1 -7.77M -2.69M -5.2M -7.77M -2.69M -5.2M
2028-03-31 2 -7.77M -2.69M -5.2M -7.77M -2.69M -5.2M
2027-12-31 3 -49.69M -17.19M -33.27M -49.69M -17.19M -33.27M
2027-09-30 2 -26.84M -9.28M -17.97M -26.84M -9.28M -17.97M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 2 -182.51M -41.32M -111.15M 8.46M 24.46M 16.37M
2028-09-30 1 -182.51M -41.32M -111.15M 8.46M 24.46M 16.37M
2028-06-30 1 -182.51M -41.32M -111.15M 8.46M 24.46M 16.37M
2028-03-31 2 -182.51M -41.32M -111.15M 8.46M 24.46M 16.37M
2027-12-31 3 -176.71M -40.01M -107.62M 54.13M 156.47M 104.75M
2027-09-30 2 -191.2M -43.29M -116.45M 29.23M 84.51M 56.57M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 2 2.69M 7.77M 5.2M 3 -0.34481 -0.0780727 -0.21
2028-09-30 1 2.69M 7.77M 5.2M 2 -0.34481 -0.0780727 -0.21
2028-06-30 1 2.69M 7.77M 5.2M 2 -0.34481 -0.0780727 -0.21
2028-03-31 2 2.69M 7.77M 5.2M 3 -0.34481 -0.0780727 -0.21
2027-12-31 3 17.19M 49.69M 33.27M 2 -0.33386 -0.07559296 -0.20333
2027-09-30 2 9.28M 26.84M 17.97M 1 -0.36123 -0.08179045 -0.22